Companies/JP/4565

ネクセラファーマ株式会社 · NXERA PHARMA CO., LTD.

Income flow

Annual
4565 ANNUAL Income StatementPeriod 2025-12-31Source ANNUAL
Net salesJPY 30B+3% Y/YRevenueJPY 30B+3% Y/YGross profitJPY 21B+1% Y/YCost of revenueJPY 8B

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).91.4MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).75.5M
Dividend calendar
Ex-dividend
2015-03-27
Last cash
2.5 · 2015-03-27
Stock splits
  1. 4:12018-06-27